Beta Bionics, Inc. · NASDAQ:BBNX
Eventide Asset Management, LLC reported a 13.40% stake in Beta Bionics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Eventide Asset Management, LLC reported a 13.40% stake in Beta Bionics, Inc., 5,945,488 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 13.40%
- Shares
- 5,945,488
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 13.40% | 5,945,488 |
| Finny Kuruvilla, M.D., Ph. D. | 13.40% | 5,945,488 |
| Robin C. John | 13.40% | 5,945,488 |
Source
Related
- Beta Bionics, Inc.
- Eventide Asset Management, LLC
- Beta Bionics, Inc. shareholders
- Schedule 13G · Eventide Asset Management, LLC · Feb 5, 2025
- Form 4 · Hopman Mark · Oct 16, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Oct 7, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4 · Jones Christy · Sep 23, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026